Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) [Phase 2]
Phase 2 ComboMATCH trial evaluating neratinib alone or with palbociclib for HER2-positive solid tumors, including malignant neoplasms of the…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial [Phase 2]
Phase 2 screening trial (ComboMATCH) sponsored by the National Cancer Institute uses genetic testing to direct targeted therapies for patien…
-
CLINICAL_TRIALS withdrawal · 2026-04-23Clinical Trial Update: AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer [Phase 1, Phase 2]
A clinical trial evaluating the combination of bevacizumab and bemarituzumab for gynecologic cancers (endometrial, ovarian, and cervical) ha…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Setting Up ctDNA Analysis on Archived Plasma Samples
The update describes a study to establish ctDNA analysis on archived plasma samples for ovarian cancer, with the trial currently active but …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study Evaluating Safety, Tolerability, and Metabolism of Niraparib [Phase 4]
A Phase 4 clinical trial evaluating safety, tolerability, and metabolism of Niraparib in ovarian cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) [Phase 3]
This update reports an ongoing Phase 3 clinical trial of Sac-TMT for non-HRD positive advanced ovarian cancer that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer [NA]
A randomized controlled trial evaluating the feasibility and preliminary efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression [Phase 3]
Phase 3 trial to compare Azenosertib (ZN-c3) against investigator's choice chemotherapy in platinum-resistant high-grade serous ovarian, pri…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors [Phase 2]
Phase II clinical trial evaluating HLX43, an anti-PD-L1 antibody-drug conjugate, for advanced gynecologic cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass
The completed trial evaluated the diagnostic utility of culdocentesis in patients with a suspicious adnexal mass. The study relates to ovari…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer
This is a non-interventional, real-world study sponsored by AstraZeneca to collect clinical and patient-reported outcomes in ovarian cancer;…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial [Phase 2]
Phase 2 study evaluating the combination of selumetinib with olaparib, or selumetinib alone, for RAS pathway-mutant recurrent or persistent …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression [Phase 2]
Phase 2 study investigating niraparib rechallenge after surgery in ovarian cancer patients with oligometastatic progression; currently recru…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of PHST001 in Advanced Solid Tumors [Phase 1]
Pheast Therapeutics is recruiting for a Phase 1 study of PHST001 in patients with advanced solid tumors, including ovarian cancer, endometri…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients [Phase 1]
This clinical trial update indicates that THEO-260 is being studied via intraperitoneal administration in ovarian cancer and is currently re…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer [Phase 1]
Phase 1 trial evaluating DT2216 in combination with paclitaxel for platinum-resistant ovarian cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of BMS-986500 as monotherapy or in combination for advanced solid tumors, including advanced breast cancer and advanc…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence [Phase 1]
Phase 1 clinical trial at University of Colorado, Denver evaluating psilocybin-assisted psychotherapy to address fear of recurrence in breas…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors [Phase 1]
This clinical trial update indicates Regor Pharmaceuticals' investigational drug RGT-490 is being studied in a Phase 1 trial for patients wi…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of valemetostat in patients with selected solid tumors, including clear cell …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinoma
This clinical trial update shows ongoing recruitment for a study assessing survival in patients with poor-prognosis epithelial ovarian carci…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
This clinical trial update describes genetic, behavioral, laboratory and epidemiologic characterization of individuals and families at high …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study …